Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03118752 · ClinicalTrials.gov registry record · NA

Pragmatic Collaborative Care for Cardiac Inpatients With Depression or Anxiety

A NA study of Depression and Heart Failure, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
290
Enrollment target
3
Study locations

NCT03118752 is a NA study of Depression and Heart Failure that has completed, run by Massachusetts General Hospital. The registered enrollment target is 290 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (63% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03118752, a NA study of Depression and Heart Failure, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
290 participants
Enrollment target
3
Study locations

Study Summary

The investigators will complete a pragmatic randomized trial (N=260 randomized participants) of the 26-week blended collaborative care (CC) intervention compared to enhanced usual care (eUC) in patients admitted for acute coronary syndrome (ACS) or heart failure (HF) found to have current depression, generalized anxiety disorder (GAD), or panic disorder (PD). The CC intervention will use a novel three-pronged approach to these high-risk patients. Care managers will provide centralized care coordination and specific interventions targeting: (1) the psychiatric disorders, (2) cardiac health behaviors, and (3) the cardiac illness. The primary study outcome will be physical function at 26 weeks, measured by the Duke Activity Status Index (DASI), given links between function and new cardiac events. The investigators will also examine effects on numerous other outcomes important to patients and healthcare systems. Specific Aim 1 \[patient-centered outcomes-primary aim\]: To compare between-group differences in the CC and eUC conditions on improvements in physical function, health-related quality of life, mental health, patient satisfaction, and other key patient-reported outcomes at 26 and 52 weeks. Specific Aim 2 \[adherence and medical outcomes\]: To compare between-group differences on health behaviors (physical activity, diet, smoking, medication adherence) and major adverse cardiac events. Specific Aim 3 \[cost\]: To compare healthcare costs between groups and assess the cost-effectiveness of CC. Hypotheses: The investigators expect this bolstered CC program to be associated with superior improvements in physical function, health-related quality of life, patient satisfaction, and adherence at 26 weeks, with promising effects on major adverse cardiac events. The investigators likewise expect the intervention to be cost-effective (\<$10,000/quality-adjusted life year) over the study period.

Interventions

  • BEHAVIORAL Collaborative Care

Study Locations (3)

Massachusetts

  • Massachusetts General Hospital - Boston
  • Brigham and Women's Hospital - Boston
  • Salem Hospital - Salem

Trial Details

FieldValue
Enrollment Target 290 participants
Start Date 2017-10-16
Est. Completion 2024-03-08
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03118752

The ClinicalTrials.gov registry entry for NCT03118752 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (63% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Collaborative Care is the first listed.

NCT03118752 reports 3 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03118752 about?

NCT03118752 is a clinical study titled "Pragmatic Collaborative Care for Cardiac Inpatients With Depression or Anxiety". The investigators will complete a pragmatic randomized trial (N=260 randomized participants) of the 26-week blended collaborative care (CC) intervention compared to enhanced usual care (eUC) in patients admitted for acute coronary syndrome (ACS) or heart failure (HF) found to have current depression...

What is the current status of trial NCT03118752?

This trial is currently completed. It is a NA study. The enrollment target is 290 participants. The study started on 2017-10-16. Estimated completion is 2024-03-08.

What conditions does trial NCT03118752 study?

This clinical trial studies the following conditions: Depression, Heart Failure, Generalized Anxiety Disorder, Acute Coronary Syndrome, Panic Disorder.

What interventions are being tested in trial NCT03118752?

The interventions under investigation include: Collaborative Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT03118752?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03118752 being conducted?

This trial has 3 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.